genotype for computation of ORs? All the samples not carrying the presented genotype combination? Or samples not carrying the presented genotype combination but carrying at least one risk genotype? The latter should be considered if it is not already the case.
-Why and how were designed the groups of protective and risk SNPs? A SNP is not by himself protective or at risk but has a risk and a protective allele. Separate analysis for "SNPs providing protection" and "SNPs providing risk" seems somehow artificial. Why not test all possibilities (e.g. risk genotype at PARK2 with risk genotype at LTA, IL-10RB2, BAT1 ...?) There is also a lack of justification for the genetic model chosen for each SNPs.
-Discussion (of the results, strengths and weaknesses of the study, meaning of the study, implications, unanswered questions, future research) is almost non-existent.
-How was made the diagnosis of Leprosy? -In table 2, results for PB or MB only are presented but they are not discussed in the manuscript. -Could population stratification be an explanation of the present findings?
REVIEWER
Monot, Marc Institut Pasteur Paris France REVIEW RETURNED 29-Nov-2013
GENERAL COMMENTS
The statistical analysis is well described in the method part of the paper.
The authors used published in-silico data to determine a target, PARK2, that contribute to the susceptibility to Leprosy.
The methods described in the paper is not enough to allow the study to be repeated, so a supplementary table is needed which describes carefully information about the 2305 samples used in the study : patient, disease forms (pauci, multi or healthy), accession number of the sequence and the genes belonging to pro-, anti-inflammatory cytokines and if available SNP-type of the Mycobaterium leprae strains.
Could you performed a genotype interaction analysis between genotype and the SNP-type of the Mycobaterium leprae strains (if available) using the same statistical method ?
Could you define the "OR" values ?
VERSION 1 -AUTHOR RESPONSE
Query 1: I'm wondering to what extent the proposed analyses really assess the combined role of the selected SNPs and interaction between those SNPs. Individual risk for each SNPs should be presented. The authors should discuss the possibility that only one variant captures the observed effect or they should explain why it is not possible if they think so. Why multivariate analysis (i.e. all variants at a time) was not conducted? Overall, the analysis strategy used to answer the question should be better justified and explained. Reply 1: As the Study involved the SNPs previously found by us to be significantly associated with Leprosy in the Indian population, providing complete individual information would have duplicated the already published information (Chopra et al, 2013; Ali et al, 2012; Aggarwal et al, 2011) . The objectives of the study were to assess the interaction among the SNPs independently associated with leprosy and then look at the pathways or networks among genes which emerged uniquely. This paves the way for precise and efficient diagnostics and therapeutics. We appreciate the Reviewer's query about the possibility for only one variant to capture the whole effect, usually which would be a possibility when there is haplo-insufficiency or complete dominance in simple diseases. Since Leprosy is a complex disease, the contribution of more than one gene and its variants is reflected and emphasized upon, as shown through overall results for all the significant SNPs towards disease susceptibility, where SNPs with only one allele were non-informative and couldn't be analyzed further.
We have used multivariate analysis in our study, considering all the SNPs together for the interaction analysis. Knowing the fact that the study includes only two categories; Cases and Controls, we chose binary logistic regression analysis for examining interaction among all SNPs together; the results have been shown in Yes, as pointed out by the reviewer, the analysis is confined to the North Indian population studied by our Laboratory in which these SNPs have shown significant association independently. We have emphasized upon this point in the revised Ms and marked the point in Red Color. Yes we have access to the replication cohort data for individual SNPs, however, when used for SNP-SNP interaction analysis, the considerable reduction in the sample size has prevented us to carry out combined interaction analysis. As pointed out by the Reviewer regarding combined analysis, we did the combined analysis of all possible SNP genotypes and selected only those combinations which were providing significant Risk or Protection; others i.e. non-significant combinations are not shown for optimizing space and better understanding. Details are provided in In this manuscript we performed multiple genotype interaction analysis of previously studied SNPs between leprosy cases and controls recruited from North Indian population. For interaction analysis (both pair-wise and multiple), all possible genotype combinations of selected SNPs in different genes were ascertained. However, only the combinations of significantly associated SNP genotypes were presented in the Ms for convenience. These interactions were tested using binary logistic regression with the forward likelihood ratio based selection method considering all variables independently. In this selection method, entry testing based on the significance of the score statistics and removal testing based on the probability of a likelihood ratio statistics were applied. Furthermore, in multiple gene interaction analysis, all interactions with either risk or protection were combined against other interactions to observe the overall effect of all risk versus protective interactions.
For all our analysis, we considered major allele as reference for computation of ORs.
In this analysis, only those genotype combinations entered into a model, which showed at least minimum threshold of significance (p value ≤ 0.05), while non-significant interactions were omitted due to constraint of size ( 
